Psychiatric comorbidity and medical illness

Medical Update for Psychiatrists

Volumn 3, Issue 3, 1998, Pages 64-70

  Stoner, Steven C ^a,b   Marken, Patricia A ^b,c   Sommi Jr , Roger W ^b,c  

^a UMKC Schools of Pharm and Medicine   (United States)

^b Northwest Missouri Psychiatric Rehabilitation Center   (United States)

^c Western Missouri Mental Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; CYTOCHROME P450; DIPHENHYDRAMINE; DOXEPIN; FLUOXETINE; FLUPHENAZINE; HYDROXYZINE; HYPNOTIC SEDATIVE AGENT; IMIPRAMINE; MAPROTILINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NEUROLEPTIC AGENT; NORTRIPTYLINE; PAROXETINE; PROTEINASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIHEXYPHENIDYL; VENLAFAXINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGED; ANXIETY NEUROSIS; CANCER PAIN; CARDIOVASCULAR DISEASE; COMORBIDITY; DEPRESSION; ENDOCRINE DISEASE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INSOMNIA; MALIGNANT NEOPLASTIC DISEASE; PANIC; PARKINSON DISEASE; PSYCHOSIS; QUALITY OF LIFE; RESPIRATION DEPRESSION; REVIEW; SEXUAL DYSFUNCTION; STROKE; TACHYCARDIA;

EID: 0031855421     PISSN: 10827579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1082-7579(98)00008-9     Document Type: Article

References (27)

1. Wells KB, Golding JM, Burnham MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry. 145:1988;976-981.
2. Fulop G, Strain JJ. Diagnosis and treatment of psychiatric disorders in medically ill patients. Hospital Community Psychiatry. 42:1991;389-394.
3. Fava GA, Sonino N. Depression associated with medical illness treatment considerations . CNS Drugs. 5:1996;175-189.
4. Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry. 150:1993;734-741.
5. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. 1994;American Psychiatric Association, Washington, DC.
6. Marsh CM. Psychiatric presentations of medical illness. Psychiat Clin North Am. 20:1997;181-204.
7. Lipowski VJ. Review of consultation psychiatry and psychosomatic medicine II Clinical aspects . Psychosomatic Med. 29:1967;201-224.
8. Barrett JE, Barrett JA, Oxman TE, Gerber PD. The prevalence of psychiatric disorders in a primary care practice. Arch Gen Psychiatry. 45:1988;1100-1106.
9. Winokur G, Black DW, Nasrallah A. Depression secondary to other psychiatric disorders in medical illnesses. Am J Psychiatry. 145:1988;233-237.
10. Wise MG, Griffies WS. A combined treatment approach to anxiety in the medically ill. J Clin Psychiatry. 56:(Suppl 2):1995;14-19.
11. Shapiro PA, Lidagoster L, Glassman AH. Depression and heart disease. Psychiatric Annals. 27:1997;347-352.
12. Sevin BH. Mitral valve prolapse, panic states, and anxiety a dilemma in perspective . Psychiat Clin North Am. 10:1987;141-150.
13. McKinnon K, Cournos F, Sugden R, Guido JR, Herman R. The relative contributions of psychiatric symptoms and AIDS knowledge to HIV risk behaviors among people with severe mental illness. J Clin Psychiatry. 57:1996;506-513.
14. Janicak PG. Psychopharmacotherapy in the HIV-infected patient. Psychiatric Annals. 25:1995;609-613.
15. Price RW, Navia BS, Cho ES. AIDS encephalopathy. Neurol Clin. 4:1986;285-301.
16. Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch JE, Bing EG, Treisman GJ. Changes in depressive symptoms as AIDS develops. Am J Psychiatry. 153:1996;1430-1437.
17. Vitiello B, Stover ES. Psychopharmacology in HIV-positive patients research perspectives . Psychopharmacol Bull. 32:1996;293-297.
18. Fernandez F, Levy JK. Psychopharmacology in HIV spectrum disorders. Psychiat Clin North Am. 17:1994;135-148.
19. Massie MJ, Holland JC. Depression and the cancer patient. J Clin Psychiatry. 51:(Suppl 7):1990;12-17.
20. Cunningham LA. Depression in the medically ill choosing and antidepressant . J Clin Psychiatry. 55:(Suppl A):1994;90-97.
21. Cummings JL. Depression, and Parkinson's disease a review . Am J Psychiatry. 149:1992;443-454.
22. Klaassen T, Verhey FRJ, Sneijders GHJM, Rozendaal N, de Vet HCW, van Praag HM. Treatment of depression in Parkinson's disease a meta-analysis . J Neuropsychiatry Clin Neurosci. 7:1995;281-286.
23. Lazarus LW, Winemiller DR, Lingam VR. Efficacy and side effects of methylphenidate for poststroke depression. J Clin Psychiatry. 53:1992;447-449.
24. Fedoroff JP, Robinson RG. Tricyclic antidepressants in the treatment of poststroke depression. J Clin Psychiatry 1989;(Suppl. 7):18-23.
25. Starkstein SE, Cohen BS, Fedoroff P, Parikh RM, Price TR, Robinson RG. Relationship between anxiety disorders and depressive disorders in patients with cerebrovascular injury. Arch Gen Psychiatry. 47:1990;246-251.
26. Tiller JWG. Post-stroke depression. Psychopharmacology. 106:(Suppl):1992;S130-S133.
27. Goodnick PJ, Kumar A, Henry JH, Buki VMV, Goldberg RB. Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol Bull. 33:1997;261-264.